There are few studies on the regression rates of high-grade CIN lesions in relation to factors such as biomarker expression (pRb, p53), local immune response, and lesion size [8,9,25,36,42,43]. This evidence concerns the gene RB1 and cervical squamous intraepithelial neoplasia.